Nitto Denko Avecia Inc., a prominent player in the biotechnology and pharmaceutical sectors, is headquartered in the United States. Founded in 1998, the company has established itself as a leader in contract development and manufacturing, specialising in advanced drug delivery systems and biologics. Avecia operates primarily in North America and has expanded its reach into key global markets. The company is renowned for its innovative core products, including plasmid DNA and viral vectors, which are pivotal in gene therapy and vaccine development. Avecia's commitment to quality and regulatory compliance has positioned it as a trusted partner for biopharmaceutical companies. With a strong focus on research and development, Nitto Denko Avecia Inc. continues to achieve significant milestones, solidifying its reputation in the competitive landscape of biomanufacturing.
We don't have data for Nitto Denko Avecia Inc., but we can show you information about their parent organization instead.
View parent company